[{"ID":"5378_12-2021_NCT02432196","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9983212575},{"ID":"30612_65-2021_NCT01557465","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is not eligible for the clinical trial. The patient is 25 years old, which is below the exclusion criteria of age < 18 years old. Therefore, option B is the correct answer.","PROBA":0.9821002553},{"ID":"35572_75-2021_NCT02730065","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9330490679},{"ID":"33729_71-2021_NCT02774668","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded.\n\nThe patient is excluded from the clinical trial because she has known liver disease (PCO).","PROBA":0.970428572},{"ID":"5443_12-2021_NCT03278574","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the patient's history of gestational diabetes mellitus, hypertension with pregnancy, and obesity, which are not related to degenerative mitral valve disease. Additionally, the patient has Marfan's syndrome, which is a genetic disorder that affects the body's connective tissue and can cause a variety of symptoms, including heart problems, but it is not considered a degenerative condition. Therefore, the patient is excluded from the clinical trial.\n\nC irrelevant because the patient has a known severe mitral valve prolapse with regurgitation, which is not the same as degenerative mitral valve disease. The patient's condition is more related to a congenital heart defect.","PROBA":0.9864347721},{"ID":"35560_75-2021_NCT02657681","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is eligible for the clinical trial. The patient has Parkinson's disease, which is the primary inclusion criterion for the study. Additionally, the patient is experiencing tremors and slow movement, which are common symptoms of Parkinson's disease and are listed as inclusion criteria in the study. The patient's Hoehn-Yahr stage is also Stage I, which is within the range of stages included in the study (Stages I-III).\n\nHowever, the patient has hypertension and hypercholesterolemia, which are not exclusion criteria for the study. The study does not exclude patients with co-morbidities, as long as the primary condition of Parkinson's disease is the main focus of the study. Therefore, the patient is eligible for the clinical trial.\n\nSo, the answer is B: eligible.","PROBA":0.9902938041},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9983154684},{"ID":"6816_15-2021_NCT02243007","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9941532612},{"ID":"5318_12-2021_NCT01708265","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9926094562},{"ID":"14106_30-2021_NCT02526719","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nC. irrelevant","PROBA":0.9986953565},{"ID":"17449_36-2021_NCT04835558","TOPIC_YEAR":2021,"RESPONSE":"$}}%A%]  A: eligible","PROBA":0.9717015136},{"ID":"6690_15-2021_NCT01252719","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9863889664},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.9999427497},{"ID":"6894_15-2021_NCT02984501","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient is not eligible for the clinical trial because they have resectable pancreatic cancer, which is an exclusion criterion. The clinical trial is only for patients with locally advanced pancreatic cancer, which the patient does not meet.","PROBA":0.9941388984},{"ID":"13974_30-2021_NCT00677469","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9563552886},{"ID":"30893_65-2021_NCT03888664","TOPIC_YEAR":2021,"RESPONSE":"$}}%C%>","PROBA":0.9999227881},{"ID":"5310_12-2021_NCT01635244","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient does not have aortic stenosis, which is a requirement for inclusion in the clinical trial. Additionally, the patient has mitral valve prolapse, which is not a condition that is being studied in the trial.","PROBA":0.970199949},{"ID":"17033_36-2021_NCT01492413","TOPIC_YEAR":2021,"RESPONSE":"$}}%A%]  A: eligible","PROBA":0.9615213275},{"ID":"6712_15-2021_NCT01442441","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is not eligible for the clinical trial because the patient has been diagnosed with pancreatic adenocarcinoma, which is not the same as chronic pancreatitis. The clinical trial is specifically focused on patients with suspected chronic pancreatitis, and the patient's diagnosis does not meet the inclusion criteria.","PROBA":0.9971545825},{"ID":"33899_71-2021_NCT04197817","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded\n\nThe patient is not eligible for the clinical trial because she has a BMI of 41.5, which is above the inclusion criteria of BMI < 35. Additionally, she has a history of sleep apnea, which is a exclusion criterion.","PROBA":0.9983492161}]
